Related Experiment Video
Updated: Dec 21, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
[Drug-drug Interactions in Intensive Care]
Drug-drug interactions are frequent in intensive care units due to high medication numbers. This review highlights pharmacokinetic interactions, crucial for safe treatment of critically ill patients.
Area of Science:
- Pharmacology
- Intensive Care Medicine
- Clinical Pharmacy
Background:
- Drug-drug interactions (DDIs) are a significant concern in intensive care units (ICUs).
- Critically ill patients often receive numerous medications (25-35 per patient), increasing the risk of DDIs.
- Understanding pharmacodynamic and pharmacokinetic interactions is vital for patient safety.
Purpose of the Study:
- To review current evidence on drug interactions in intensive care patients.
- To emphasize pharmacokinetic mechanisms as a primary cause of clinically relevant DDIs.
- To discuss common drug classes involved in ICUs.
Main Methods:
- Literature review of existing studies on drug interactions in intensive care settings.
- Focus on pharmacokinetic and pharmacodynamic interactions.
- Inclusion of a clinical case example.
Main Results:
- Pharmacokinetic interactions are frequently implicated in DDIs among ICU patients.
- Key drug classes involved include analgesics, sedatives, antibiotics, antimycotics, antiepileptics, immunosuppressants, prokinetics, and gastric acid regulators.
- Pharmacodynamic interactions such as QTc prolongation and serotonin syndrome are also noted.
Conclusions:
- Drug interactions, particularly pharmacokinetic ones, pose significant risks in ICUs.
- Awareness and management of DDIs are essential for optimizing treatment safety in critically ill patients.
- A case of severe hypertension exacerbated by rifampin and antihypertensives illustrates the potential impact of DDIs.
Related Concept Videos
Pharmacokinetics: Drug–Drug Interactions
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Acute Kidney Injury V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Acute Kidney Injury VI: Nursing Management

